Answers are grounded in this paper and cite their sources.
Identification of novel therapeutic targets in ER active and mutant endometrial cancer
No takes yet. Share an insight, caveat, or question.
Blanchard et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: